Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens
The Journal of Applied Laboratory Medicine · 2025
DOI: 10.1093/jalm/jfaf010 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, 2025. Verfasst von Elizabeth M Garrett und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Penn State College of Medicine, Hershey, PA, United States. Hauptthemen laut MEDLINE: Clostridioides difficile, Glutamate Dehydrogenase, Bacterial Toxins, Clostridium Infections. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Clostridioides difficile infection (CDI) is a leading cause of nosocomial infections in the United States, causing longer hospital stays, significant morbidity, and increased healthcare costs. Accurate CDI diagnosis is essential for timely treatment and infection control. Laboratory diagnosis of CDI commonly involves the detection of glutamate dehydrogenase (GDH) and/or toxins A and B by immunoassays or the toxin genes by nucleic acid amplification. This study assesses the performance of a new commercial test, the Sofia® 2 C. difficile Fluorescent Immunoassay (Sofia 2; FIA; QuidelOrtho), for detecting C. difficile GDH and toxins.
Methods
Sofia 2 was compared to enzyme immunoassays (EIAs) C. diff Quik Chek Complete (Techlab Inc.) and Immunocard (Meridian Bioscience) using remnant stool samples from 262 patients with suspected CDI.
Results
Sofia 2 demonstrated high agreement with the EIA methods for GDH (positive percentage agreement (PPA): 100%, negative percentage agreement (NPA): 94%, overall percentage of agreement (OPA): 95%) and toxins (PPA: 100%, NPA: 99%, OPA: 99%) detection. Compared to standard-of-care (SOC) testing including toxin gene PCR with the following toxin antigen test, Sofia 2 demonstrates strong PPA (100%), NPA (98%), positive predictive value (71%), and negative predictive value (100%).
Conclusions
Sofia 2 C. difficile FIA generates rapid results that are comparable to other commercial immunoassays with a simple workflow, supporting its use for CDI diagnosis in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Penn State College of Medicine, Hershey, PA, United States.
ORCID-Profile: Elizabeth M Garrett
Zitieren
APA
Garrett, E. M., Pu, M., & Bobenchik, A. M. (2025). Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfaf010
Vancouver
Garrett EM, Pu M, Bobenchik AM. Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens. The Journal of Applied Laboratory Medicine. 2025. doi:10.1093/jalm/jfaf010
BibTeX
@article{Garrett2025,
author = {Garrett, Elizabeth M and Pu, Meng and Bobenchik, April M},
title = {Evaluation of a Fluorescence Immunoassay for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin Antigens},
journal = {The Journal of Applied Laboratory Medicine},
year = {2025},
doi = {10.1093/jalm/jfaf010}
}
EUVIMED